2464
H.J.M. Gijsen et al. / Tetrahedron 64 (2008) 2456e2464
2.77 (1H, dt, J¼12.5, 3.4 Hz), 2.94 (1H, dd, J¼12.1, 4.4 Hz),
3.38 (1H, td, J¼9.7, 4.4 Hz). MS (EIþ) m/z (rel intensity) 126
(51%, Mþ), 97 (11%), 72 (14%), 57 (100%).
2.70 (1H, ddd, J¼11.5, 9.5, 3.8 Hz), 2.75 (1H, m), 3.46 (1H,
tt, J¼9.6, 5.0 Hz), 3.77 (1H, d, J¼13.5 Hz), 3.91 (1H, br s),
5.79 (1H, d, J¼5.5 Hz).
4.18. (ꢂ)-1-(Phenylmethyl)-(trans)-4-(aminomethyl)-
piperidin-3-ol (31)
4.21. (ꢂ)-1,1-Dimethylethyl trans-4-(aminomethyl)-3-
hydroxy-1-piperidinecarboxylate (14)
Compound 26 (130 g, 0.6 mol) in a 7 N NH3/MeOH solu-
tion (1.5 l) was hydrogenated at 14 ꢁC with Raney nickel as
a catalyst (20 g). After uptake of 2 equiv of hydrogen, the cat-
alyst was filtered off and the solvent was evaporated. The res-
idue was dissolved in MeCN and filtered to remove remaining
solids. The filtrate was concentrated again under reduced pres-
sure and the residue was treated with diisopropyl ether to af-
ford crystalline 31 (107 g, 81%), mp 74 ꢁC. 1H NMR
(360 MHz, CDCl3) d ppm 1.21 (1H, qd, J¼12.4, 4.0 Hz),
1.25e1.39 (1H, m), 1.51 (1H, dq, J¼12.7, 2.8 Hz), 1.85
(1H, t, J¼10.1 Hz), 1.95 (1H, td, J¼11.4, 2.7 Hz), 2.68 (1H,
dd, J¼12.1, 10.6 Hz), 2.82 (1H, br d, J¼11.3 Hz), 2.96 (2H,
br s), 3.02e3.09 (2H, m), 3.54 (2H, s), 3.68 (1H, td, J¼9.3,
4.4 Hz), 7.20e7.28 (1H, m), 7.28e7.34 (4H, m). Anal. Calcd
for C13H20N2O: C, 70.87; H, 9.15; N, 12.72. Found: C, 70.53;
H, 9.05; N, 12.46.
Nitrile 34 could be reduced via catalytic hydrogenation to
14 using the same procedure as described for 31 in quantitative
yield. The analytical data were identical to the previously pre-
pared 14 (vide supra).
References and notes
1. De Maeyer, J. H.; Prins, N. H.; Schuurkes, J. A. J.; Levebvre, R. A.
J. Pharmacol. Exp. Ther. 2006, 317, 955e964.
2. (a) Buffat, M. G. P. Tetrahedron 2004, 60, 1701e1729; (b) Weintraub,
P. M.; Sabol, J. S.; Kane, J. M.; Borcherding, D. R. Tetrahedron 2003,
59, 2953e2989 and references cited in these reviews.
3. Sonda, S.; Kawahara, T.; Ktayama, K.; Sato, N.; Asano, K. Bioorg. Med.
Chem. 2005, 13, 3295e3308.
4. For example: (a) Efange, S. M. N.; Khare, A. B.; Foulon, C.; Akella, S. K.;
Parsons, S. M. J. Med. Chem. 1994, 37, 2574e2582; (b) Naito, T.;
Nakagawa, K.; Nakamura, T.; Kasei, A.; Ninomiya, I.; Kiguchi, T.
J. Org. Chem. 1999, 64, 2003e2009; (c) Langlois, N.; Calvez, O. Synth.
Commun. 1998, 28, 4471e4478; (d) Marquis, R. W.; Yamashita, D. S.;
Ru, Y.; LoCastro, S. M.; Oh, H.-J.; Erhard, K. F.; DesJarlais, R. L.;
Head, M. S.; Smith, W. W.; Zhao, B.; Janson, C. A.; Abdel-Mgeguid,
S. S.; Tomaszed, T. A.; Levy, M. A.; Veber, D. F. J. Med. Chem. 1998,
41, 3563e3567; (e) Kubota, D.; Ishikawa, M.; Ishikawa, M.; Yahata,
N.; Murakami, S.; Fujishima, K.; Kitakaze, M.; Ajito, K. Bioorg. Med.
Chem. 2006, 14, 4158e4181.
4.19. (ꢂ)-trans-4-(Aminomethyl)-piperidin-3-ol (33)
To a solution of 14 (HCl salt, 58 g, 0.22 mol) in isopropanol
(2.2 L) was added a 6 N HCl solution in isopropanol (220 mL)
and the mixture was refluxed for 30 min. The reaction mixture
was concentrated under reduced pressure and the residue co-
evaporated with toluene (500 mL). The solid residue was sus-
pended in diisopropyl ether. The solid was filtered off and
dried in vacuo to give 33 as a double HCl salt (43 g, 98%),
5. (a) Lewis, N. J.; Barker, K. K.; Fox, R. M.; Mertes, M. P. J. Med. Chem.
1973, 16, 156e159; (b) Furegati, S.; Ganci, W.; Gorla, F.; Ringeisen, U.;
Rueedi, P. Helv. Chim. Acta 2004, 87, 2629e2661.
6. (a) Petrow, V.; Stephenson, O. J. Pharm. Pharmacol. 1962, 14, 306e314;
(b) Moriconi, E. J.; Misner, R. E. J. Org. Chem. 1969, 34, 3672e3674.
7. Brown, H. C. Hydroboration; W.A. Benjamin: New York, NY, 1962.
8. (a) Kergomard, A.; Veschambre, H. Tetrahedron Lett. 1976, 17, 4069e
4072; (b) Golodova, K. G.; Yakimovitch, S. I. Zh. Org. Khim. 1972, 8,
2481e2489.
1
mp 237 ꢁC. H NMR (360 MHz, DMSO-d6) d ppm 1.37e
1.53 (1H, m), 1.72e1.85 (1H, m), 1.99 (1H, dq, J¼14.3,
3.3 Hz), 2.56e2.69 (2H, m), 2.75 (1H, br t, J¼11.5 Hz),
3.08 (1H, d, J¼9.9 Hz), 3.12e3.23 (2H, m), 3.53e3.66 (1H,
m), 5.84 (1H, d, J¼4.8 Hz), 8.16 (3H, br s), 9.38 (2H, br s).
Anal. Calcd for C6H14N2O$2HCl: C, 35.48; H, 7.94; N,
13.79. Found: C, 35.46; H, 7.81; N, 14.33.
9. Takemura, S.; Miki, Y.; Uono, M. i; Yoshimura, K.; Kuroda, M.; Suzuki,
A. Chem. Pharm. Bull. 1981, 29, 3026e3032.
10. Imanishi, T.; Shin, H.; Hanaoka, M.; Momose, T.; Imanishi, I. Chem.
Pharm. Bull. 1982, 30, 3617e3623.
11. Ciaccio, J. A.; Stanescu, C.; Bontemps, J. Tetrahedron Lett. 1992, 33,
1431e1434.
4.20. (ꢂ)-1,1-Dimethylethyl trans-4-cyano-3-hydroxy-1-
piperidinecarboxylate (34)
12. Livinghouse, T. Org. Synth. Coll. 1990, 7, 517e522.
13. Recently, the epoxidation of 17 to 24, using similar conditions as
described here, was published: Grishina, G. V.; Borisenko, A. A.; Veselov,
I. S.; Petrenko, A. M. Russ. J. Org. Chem. 2005, 41, 272e278.
14. Ciaccio, J. A.; Smrtka, M.; Maio, W. A.; Rucando, D. Tetrahedron Lett.
2004, 45, 7201e7204.
To a solution of 30 (32.8 g, 0.26 mol) in methanol
(290 mL) was added (Boc)2O (69 g, 0.32 mol) at room tem-
perature and the reaction mixture was stirred at room temper-
ature overnight. Water (150 mL) was added and the mixture
was stirred for an additional 4 h at room temperature. The
methanol was evaporated under reduced pressure at room tem-
perature and the resulting mixture was extracted with CH2Cl2
(450 mL). The organic layer was dried on Na2SO4 and con-
centrated under reduced pressure to give 34 (54 g, 92%) as
an oil, which could be used as such in the next step. 1H
NMR (360 MHz, DMSO-d6) d ppm 1.39 (9H, s), 1.50e1.62
(1H, m), 1.98 (1H, dq, J¼13.4, 3.2 Hz), 2.57 (1H, br s),
15. (a) Bosmans, J.-.P. R. M. A.; De Cleyn, M. A. J.; Surkyn, M. PCT Int.
Appl. WO199902156, 1999; Chem. Abstr. 1999, 130, 139258; (b)
Bosmans, J.-.P. R. M. A.; Gijsen, H. J. M.; Mevellec, L. A. PCT Int.
Appl. WO2005000838, 2005; Chem. Abstr. 2005, 142, 114101.
16. Laduron, F.; Tamborowski, V.; Moens, L.; Horvath, A.; De Smaele, D.;
Leurs, S. Org. Process Res. Dev. 2005, 9, 102e104.
17. Racemic 14 could be resolved with S-(þ)-mandelic acid in isopropanol to
give enantiopure 3S,4S-14 as the S-(þ)-mandelic acid salt. Standard acide
base extraction then provided 3S,4S-14: [a]D þ4.4 (c 0.5, MeOH), with
further analytical data in agreement with the racemic 14.